Comparative Efficacy of Duloxetine vs Escitalopram in Patients With Fibromyalgia
Status:
Completed
Trial end date:
2020-02-26
Target enrollment:
Participant gender:
Summary
Duloxetine is FDA approved as pharmacological treatment for Fibromyalgia. The use of SSRIs
has been endorsed by the 2013 Canadian guidelines. The data available for Escitalopram as a
treatment modality for Fibromyalgia is limited, however small trials have demonstrated its
efficacy. No head to head comparisons between escitalopram and duloxetine have been
undertaken. We aim to conduct a single blind, randomized control trial to assess the
comparative efficacy of duloxetine vs escitalopram in drug naive patients with newly
diagnosed Fibromyalgia.